Can I read Dapagliflozin in Patients With Systolic HF, 24-1 on EtoBox?

Dapagliflozin in Patients With Systolic HF, 24-1 by Muhammad Tahir is a document available to read on EtoBox.

What is Dapagliflozin in Patients With Systolic HF, 24-1 about?

This study investigates the efficacy of dapagliflozin in patients with systolic heart failure, revealing that it significantly reduces the risk of worsening heart failure and cardiovascular mortality compared to a placebo. Conducted over one year with 1,470 patients, the results indicate improved symptoms and lower hospitalization rates in those treated with dapagliflozin. The findings support the use of this SGLT-2 inhibitor as a beneficial treatment option for heart failure patients, regardless of diabete

Author

Muhammad Tahir

Language

EN